Having trouble accessing articles? Reset your cache.

RTN4 and S1PR2 identified as targets for stroke

DISEASE CATEGORY: Neurology

INDICATION: Stroke

A team led by NovaGo Therapeutics co-founder Martin Schwab showed inhibition of RTN4

Read the full 164 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE